📊 BON Key Takeaways
Is Bon Natural Life Ltd (BON) a Good Investment?
Bon Natural Life Ltd presents severe fundamental analysis challenges with virtually no available financial data across income statement, balance sheet, and cash flow metrics. The company appears to have minimal or no reported operational activity, with only 1 metric available out of comprehensive financial data requirements, indicating either a shell company, pre-revenue entity, or serious reporting deficiencies.
Bon Natural Life’s fundamentals show weak growth quality: revenue fell from $29.5 million in FY2023 to $23.8 million in FY2024, then declined another 21.9% year over year in the first half of FY2025. While profitability remained technically positive, earnings are thin and cash conversion is poor, with large operating cash outflows driven by receivables, supplier advances, and other working-capital swings, making the business dependent on external financing rather than internally generated cash.
Why Buy Bon Natural Life Ltd Stock? BON Key Strengths
- No strengths identified
- The company remained profitable in FY2024 and returned to positive net income in the first half of FY2025 after a small loss in the prior-year period.
- Balance-sheet leverage is not extreme relative to reported equity, with shareholders’ equity materially exceeding total liabilities.
- Operating expenses improved in the first half of FY2025, helping operating income rise despite lower revenue.
BON Stock Risks: Bon Natural Life Ltd Investment Risks
- Complete absence of revenue and profitability data
- No balance sheet metrics available indicating potential non-reporting status
- Zero cash flow visibility across operating, investing, and financing activities
- No insider trading activity in past 90 days suggesting lack of management confidence
- Impossible to assess financial health, solvency, or operational quality
- Medicinal/botanical sector requires strong fundamentals - none demonstrated here
- Revenue has been contracting sharply, indicating weak demand durability and poor top-line momentum.
- Operating cash flow is deeply negative, and recent cash increases came mainly from share issuance and borrowing rather than the core business.
- Asset quality is a concern because a large portion of current assets is tied up in accounts receivable, supplier advances, related-party balances, and a long-term receivable tied to asset-sale proceeds.
Key Metrics to Watch
- Revenue recognition and gross margins once reported
- Operating cash flow generation capability
- Balance sheet strength including working capital position
- Operating cash flow versus net income
- Accounts receivable and advance-to-suppliers balances as a percentage of revenue
Bon Natural Life Ltd (BON) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BON Profit Margin, ROE & Profitability Analysis
BON vs Materials Sector: How Bon Natural Life Ltd Compares
How Bon Natural Life Ltd compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Bon Natural Life Ltd Stock Overvalued? BON Valuation Analysis 2026
Based on fundamental analysis, Bon Natural Life Ltd has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Bon Natural Life Ltd Balance Sheet: BON Debt, Cash & Liquidity
BON Revenue Growth, EPS Growth & YoY Performance
BON SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Bon Natural Life Ltd (CIK: 0001816815)
❓ Frequently Asked Questions about BON
What is the AI rating for BON?
Bon Natural Life Ltd (BON) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 89% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BON's key strengths?
Claude: . ChatGPT: The company remained profitable in FY2024 and returned to positive net income in the first half of FY2025 after a small loss in the prior-year period.. Balance-sheet leverage is not extreme relative to reported equity, with shareholders’ equity materially exceeding total liabilities..
What are the risks of investing in BON?
Claude: Complete absence of revenue and profitability data. No balance sheet metrics available indicating potential non-reporting status. ChatGPT: Revenue has been contracting sharply, indicating weak demand durability and poor top-line momentum.. Operating cash flow is deeply negative, and recent cash increases came mainly from share issuance and borrowing rather than the core business..
What is BON's revenue and growth?
Bon Natural Life Ltd reported revenue of N/A.
Does BON pay dividends?
Bon Natural Life Ltd does not currently pay dividends.
Where can I find BON SEC filings?
Official SEC filings for Bon Natural Life Ltd (CIK: 0001816815) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BON's EPS?
Bon Natural Life Ltd has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BON a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Bon Natural Life Ltd has a SELL rating with 89% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BON stock overvalued or undervalued?
Valuation metrics for BON: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy BON stock in 2026?
Our dual AI analysis gives Bon Natural Life Ltd a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is BON's free cash flow?
Bon Natural Life Ltd's operating cash flow is N/A, with capital expenditures of N/A.
How does BON compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).